FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084294 [Registered on: 07/04/2025] Trial Registered Prospectively
Last Modified On: 07/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A study on Siddha Medicine (Maruthampattai chooranam) for Dyslipidemia among Outpatients attending Ayothidoss pandithar hospital. 
Scientific Title of Study   An Open Phase II Clinical trial to evaluate the therapeutic effectiveness of Maruthampattai chooranam in the management of Athimetham(Dyslipidemia) among Outpatients attending Ayothidoss Pandithar Hospital,National Institute of Siddha 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr ASWINI J V 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium

Chennai
TAMIL NADU
600047
India 
Phone  9488924048  
Fax    
Email  aswinijv81298@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr T LAKSHMIKANTHAM 
Designation  Professor 
Affiliation  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium

Chennai
TAMIL NADU
600047
India 
Phone  9025575185  
Fax    
Email  drlakshmiramaswamy@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr H Vetha Merlin Kumari 
Designation  Professor 
Affiliation  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium

Chennai
TAMIL NADU
600047
India 
Phone  9894782366  
Fax    
Email  dr.vetha@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Siddha,Tambaram Sanatorium,Chennai-47 
 
Primary Sponsor  
Name  National Institute of Siddha 
Address  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium, Chennai-47 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr J V ASWINI   Ayothidoss Pandithar Hospital  Room no 7/8, Department of Maruthuvam, National Institute of Siddha, Tambaram Sanatorium
Chennai
TAMIL NADU 
9488924048

aswinijv81298@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, NATIONAL INSTITUTE OF SIDDHA,CHENNAI 600047  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E785||Hyperlipidemia, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Maruthampattai chooranam  Maruthampattai chooranam-2 grams Bd with Hotwater, Oral route of administration for the period of 90 days 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Participants attending Obesity Special OPD will be screened for Dyslipidemia.
2.Participants with newly identified Dyslipidemia will be included.
3.Participants having any one or all of the following altered lipid levels will be selected. (ATP III Guidelines, NCEP-National Cholesterol Education Program)
Total cholesterol more than 200mg/dl
LDL cholesterol more than 130mg/dl
HDL cholesterol less than 40 mg/dl
Triglyceride more than 150 mg/dl

 
 
ExclusionCriteria 
Details  1.Participants with chronic kidney diseases.
2.Participants with Active vascular disease
(e.g. Unstable angina, stroke).
3.K/C/O coronary heart disease
4.K/C/O Liver diseases such as Hepatitis, Cirrhosis.
5.K/C/O Thyroid dysfuntion.
6.Chronic Smokers/Alcoholics

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Outcome of the Study will be assessed by comparing the changes in the Lipid Profile before and after Treatment.  at Baseline and 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   23/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

  BACKGROUND:

Siddha Medicine is one of the most ancient systems of Medicine in the World. It is mainly based on three vital humours namely Vazhi, Azhal and Iyam. It contributes in treating the disease as well as play an important role in rejuvenating the body and mind. One of the Special therapy in Siddha System of Medicine is use of Single herbal therapy for various Diseases.According to Siddha literature, Human body is mainly composed of seven udal thathukal. Kozhuppu thathu is one among them. As per TV Sambasivam Pillai dictionary, the word “Athi” means Athigam or Miguthi and the word “Metham” means Kozhuppu. The disease ATHIMETHAM may be correlated to Dyslipidemia (ICD-10 Code E78. 5)According to Siddha Text, Principles of Diagnosis in Siddha, Kozhuppu helps the function of each organ of the body by making them greasy. Increase in Kozhuppu thathu of the body causes Tiresomeness, dyspnoea even during very light work. Increase in Kozhuppu thathu also leads to formation of hanging muscles on the buttocks, the chest, stomach and the thighs . It relates to Obesity. The "Health of the Nation 2023" report has revealed a 50% rise in obesity rates and an 18% increase in Hyperlipidemia among Indians from 2019 to 2022.Dyslipidemia (Hyperlipoproteinemia/Hyperlipidemia) is a condition characterized by an elevation of any or all parameters of lipid profile or lipoprotein levels in the blood. There are several risk factors associated with Hyperlipidemia such as Diabetes, Obesity, Hypertension, Hypothyroidism, sedentary life style, fatty/oily diets, excess alcohol intake and smoking .

The World Health Organization (WHO) reports that high cholesterol contributes to 56% of Global heart disease and 18% Global stroke events. It responsible for more than 4 million deaths each year. In most parts of the world, the number of female deaths attributed to high cholesterol is slightly higher than the number of male deaths .In 2023, 75% of patients still exceed the target levels for low-density lipoprotein cholesterol (LDL-C), making hypercholesterolemia both the most prevalent and poorly managed Cardiovascular risk factor. With early diagnosis, we could potentially prevent several million deaths.In Siddha system of Medicine, there was large collection of herbal medicines treating various disease. Evidence based research supports the role of Siddha Medicinal plants in reducing Dyslipidemia. Availability of a wide range of allopathic hypolipidemic like statins and fibrate, they have not gained popularity due to their significant side effects such as rhabdomyolysis, hyperuricemia and hepatotoxicity. Considering the wide magnitude of lipid disorders and the absence of promising remedies with safety in Conventional systems, the suffering population is turning towards other systems of Medicine for safe and effective remedies. Maruthampattai had various chemical constituents such as Polyphenols, Flavonoid, tannins, etc which helps in treating hyperlipidemia.This study aims to evaluate the therapeutic effectiveness of Siddha Medicine Single herbal drug by name MARUTHAMPATTAI CHOORANAM in the management of ATHIMETHAM (Dyslipidemia).

OBJECTIVE:

                  To evaluate the therapeutic effectiveness of Siddha Medicine “MARUTHAMPATTAI CHOORANAM in the management of Athimetham (Dyslipidemia) by comparing the changes in the Lipid profile before and after treatment.

                  STUDY TYPE:                 Interventional study

                        STUDY DESIGN:            Open Phase II Clinical Trial

    STUDY PLACE:              Department of Maruthuvam,

                                                                    OPD of Ayothidoss Pandithar Hospital, National Institute of Siddha, Tambaram sanatorium, Chennai 47.

                        STUDY PERIOD:            18 months

                        SAMPLING METHOD: Consecutive sampling

                        SAMPLE SIZE:               30 Patients

 INCLUSION CRITERIA:

  • Age group: 30-60 years .
  • Sex: Male, Female, Transgender.
  • Participants attending Obesity Special OPD will be screened for Dyslipidemia.
  • Participants with newly identified Dyslipidemia will be included.
  • Participants having any one or all of the following altered lipid levels will be selected. (ATP III Guidelines, NCEP-National Cholesterol Education Program)

            Total cholesterol more than 200mg/dl

            LDL cholesterol  more than 130mg/dl 

            HDL cholesterol less than 40 mg/dl 

              Triglyceride  more than 150 mg/dl

EXCLUSION CRITERIA:

  •       Participants with chronic kidney diseases.
  •       Participants with Active vascular disease (e.g. Unstable angina, stroke).
  •       K/C/O coronary heart disease.
  •       K/C/O Liver diseases such as Hepatitis, Cirrhosis.
  •       K/C/O Thyroid dysfuntion.
  •       Chronic Smokers/Alcoholics.

OUTCOME OF TREATMENT [Time Points-90 days]:

                                        The outcome of the Study will be assessed by comparing the changes in the Lipid Profile before and after Treatment.

RESUTS AND DISCUSSION:

                The results will be statistically analysed and reported.

KEYWORDS: Dyslipidemia,Maruthampattai chooranam,Athimetham

 
Close